Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Impax Laboratories Inc (IPXL)  
$6.76 0.55 (8.86%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 159,210,000
Market Cap: 1.08(B)
Last Volume: 2,204,422 Avg Vol: 2,198,299
52 Week Range: $1.78 - $6.34
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amneal Pharmaceuticals is a holding company. Through its subsidiaries, Co. is a pharmaceutical company engaging in developing, manufacturing, marketing and distributing generic and branded pharmaceutical products across an array of dosage forms and therapeutic areas. Co. has three reportable segments: Generics, which includes various product families covering a range of dosage forms and delivery systems; Specialty, which is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products, with a focus on products addressing central nervous system disorders; and AvKARE, which provides pharmaceuticals, medical and surgical products, and services.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 215
  Page 4 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Nestor Michael President, Impax Pharm.   •       •      –    2016-05-23 4 D $32.12 $54,476 D/D (1,696) 123,096     -
   Benet Leslie Z Director   •       •      –    2016-05-17 4 A $0.00 $0 D/D 4,375 20,225     -
   Burr Robert L Director   •       •      –    2016-05-17 4 A $0.00 $0 D/D 4,375 56,100     -
   Chao Allen Director   •       •      –    2016-05-17 4 A $0.00 $0 D/D 4,375 65,070     -
   Terreri Peter R Director   •       •      –    2016-05-17 4 A $0.00 $0 D/D 4,375 44,162     -
   Pendergast Mary K Director   •       •      –    2016-05-17 4 A $0.00 $0 D/D 4,375 17,975     -
   Vergis Janet S. Director   •       •      –    2016-05-17 4 A $0.00 $0 D/D 4,375 7,775     -
   Schlossberg Mark A SVP and General Counsel   •       •      –    2016-05-15 4 D $29.18 $67,989 D/D (2,330) 89,016     -
   Nestor Michael President, Impax Pharm.   •       •      –    2016-05-15 4 D $29.18 $94,426 D/D (3,236) 124,792     -
   Reasons Bryan M. Chief Financial Officer   •       •      –    2016-05-15 4 D $29.18 $35,483 D/D (1,216) 88,705     -
   Schlossberg Mark A SVP and General Counsel   •       •      –    2016-05-14 4 D $29.18 $63,116 D/D (2,163) 91,346     -
   Nestor Michael President, Impax Pharm.   •       •      –    2016-05-14 4 D $29.18 $87,628 D/D (3,003) 128,028     -
   Reasons Bryan M. Chief Financial Officer   •       •      –    2016-05-14 4 D $29.18 $55,121 D/D (1,889) 89,921     -
   Nornhold Jeffrey SVP, Technical Operations   •       •      –    2016-05-14 4 D $29.18 $9,834 D/D (337) 79,976     -
   Wilkinson George Fred Chief Executive Officer   •       •      –    2016-04-29 4/A D $33.35 $3,242,254 D/D (97,219) 429,237     -
   Wilkinson George Fred Chief Executive Officer   •       •      –    2016-04-29 4 D $33.35 $2,054,160 D/D (61,594) 464,862     -
   Reasons Bryan M. Chief Financial Officer   •       •      –    2016-04-13 4 D $35.35 $36,587 D/D (1,035) 91,810     -
   Benet Leslie Z Director   •       •      –    2016-03-14 4 OE $6.55 $22,925 D/D 3,500 15,850     -
   Schlossberg Mark A SVP and General Counsel   •       •      –    2016-02-26 4 A $0.00 $0 D/D 21,852 93,509     -
   Schlossberg Mark A SVP and General Counsel   •       •      –    2016-02-26 4 D $33.27 $64,244 D/D (1,931) 71,657     -
   Nestor Michael President, Impax Pharm.   •       •      –    2016-02-26 4 A $0.00 $0 D/D 21,852 131,031     -
   Nestor Michael President, Impax Pharm.   •       •      –    2016-02-26 4 D $33.27 $88,299 D/D (2,654) 109,179     -
   Nornhold Jeffrey SVP, Technical Operations   •       •      –    2016-02-26 4 A $0.00 $0 D/D 17,317 80,313     -
   Nornhold Jeffrey SVP, Technical Operations   •       •      –    2016-02-26 4 D $33.27 $40,057 D/D (1,204) 62,996     -
   Reasons Bryan M. Chief Financial Officer   •       •      –    2016-02-26 4 A $0.00 $0 D/D 26,113 92,845     -
  215 Records found
  1  2  3  4  5  6  7  8  9   
  Page 4 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us